Exagen (XGN) Return on Capital Employed (2019 - 2026)
Exagen (XGN) reported Return on Capital Employed of 33.28% for Q1 2026, up 1584.0% on a YoY basis from 1.98% in Q1 2025, and down 9.43% quarter-over-quarter from 30.41% in Q4 2025.
Exagen (XGN) Return on Capital Employed (2019 - 2026) Analysis & Trends
Exagen has reported Return on Capital Employed for 8 years, with the latest figure at 33.28% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 1584.0% year-over-year to 33.28%; the trailing twelve-month figure through Mar 2026 stood at 33.28% (up 1584.0% YoY), and the FY2025 full-year result was 37.83%, down 128.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 33.28%, down from 30.41% in the prior quarter.
- The five-year high for Return on Capital Employed was 25.42% in Q1 2022, with the low at 61.37% in Q3 2023.
- Historically, Return on Capital Employed has averaged 42.36% across 5 years, with a median of 40.71% in 2022.
- Annual changes were most pronounced in 2023 — Return on Capital Employed slumped 3458 bps — and 2024, when it soared 2050 bps.
- Exagen's Return on Capital Employed stood at 54.64% in 2022, then advanced by 11 bps to 48.55% in 2023, then rose by 8 bps to 44.5% in 2024, then soared by 32 bps to 30.41% in 2025, then slipped by 9 bps to 33.28% in 2026.
- The last three Return on Capital Employed figures came in at 33.28% (Q1 2026), 30.41% (Q4 2025), and 26.05% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 4.82% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 8.12% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 6.26% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 67.98% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 14.57% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -3.63% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 10.24% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 16.90% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 45.73% |
| 10 | Exagen | 102.82 Mn | 81.30 Mn | 10.21 Mn | -33.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.28% |
| Dec 31, 2025 | -30.41% |
| Sep 30, 2025 | -26.05% |
| Jun 30, 2025 | -35.79% |
| Mar 31, 2025 | -49.12% |
| Dec 31, 2024 | -44.50% |
| Sep 30, 2024 | -40.87% |
| Jun 30, 2024 | -38.92% |
| Mar 31, 2024 | -40.21% |
| Dec 31, 2023 | -48.55% |
| Sep 30, 2023 | -61.37% |
| Jun 30, 2023 | -55.35% |
| Mar 31, 2023 | -60.00% |
| Dec 31, 2022 | -54.64% |
| Sep 30, 2022 | -40.71% |
| Jun 30, 2022 | -34.97% |
| Mar 31, 2022 | -25.42% |
| Dec 31, 2021 | -20.70% |
| Sep 30, 2021 | -16.80% |
| Jun 30, 2021 | -14.04% |